Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 712836 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Search Results

Your Search for 'Intellectual Property Licensing: Forms and Analysis' returned 369 results - Page 1 of 19

  Sort by   
  Sorted by Rank Top-Bottom

Competition Law and Intellectual Property Strategy in Pharmaceuticals Sector  
PharmaVentures, April 2008, Pages: 149
system 45 46 Enforcement of intellectual property rights as a breach of EC competition law 47 47 Refusal to license intellectual property rights as an abuse of dominant position 48 48 Patent dispute


EDA Tools - Global Strategic Business Report  
Global Industry Analysts, Inc., Feb 2010, Pages: 394
Board (PCB) Layout Tools, Semiconductor Intellectual Property (SIP), and Services. Annual forecasts are provided for the period 2007 through 2015. Also, a five-year historic analysis is provided


Opportunities in Human Embryonic Stem Cell (hESC) Products  
BioInformant, Jan 2010, Pages: 126
of these significant accomplishments at the University of Wisconsin, the Wisconsin Alumni Research Foundation (WARF) filed a series of landmark patents that have affected the intellectual property landscape ever since


Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force  
GBI Research, Aug 2011, Pages: 108
in India 38 5.6.1 Pricing of Pharmaceutical Drugs in India 38 5.6.2 Reimbursements of Pharmaceutical Drugs in India 38 5.7 Intellectual Property Rights in India 42 5.7.1 Effect of Patent Laws


Nanotechnology - Global Strategic Business Report  
Global Industry Analysts, Inc., Oct 2010, Pages: 2423
91 Investment Issues and High Costs Delay Rapid Commercialization 91 Guarded and Protective Stance on Intellectual Property & Open Knowledge-Sharing


Palau Pharma S.A - Product Pipeline Review - Q4 2010  
Global Markets Direct, Dec 2010, Pages: 59
with Palau Pharma S.A. - Avoid Intellectual Property Rights related issues. - Explore the dormant and discontinued projects of Palau Pharma S.A and identify potential opportunities in those areas


Molecular Diagnostics - Global Strategic Business Report  
Global Industry Analysts, Inc., Oct 2010, Pages: 659
Into Collaborations for Pancreatic Cancer Tests 71 Transgenomic Licenses Intellectual Property from Integragen 71 Health Discovery Inks Agreement with Pancreas, Biliary and Liver Surgery Center of New York 71


Kyowa Hakko Kirin Co., Ltd. - Product Pipeline Review - H2 2011  
Global Markets Direct, Nov 2011, Pages: 190
., Ltd.. - Avoid Intellectual Property Rights related issues. - Explore the dormant and discontinued projects of Kyowa Hakko Kirin Co., Ltd. and identify potential opportunities in those areas. Keywords


RNA interference (RNAi) - Global Strategic Business Report  
Global Industry Analysts, Inc., April 2011, Pages: 802
.Market Analysis 124 Outlook 124 Strategic Corporate Developments 124 Cenix Receives R&D Grant from Saxony 124 Marina Biotech Acquires Novosom's SMARTICLES® Intellectual Property Estate 124 Astra


The Future of R&D Outsourcing: Investigating Development Hurdles, Key Challenges & Strategies to Optimize CRO Relationships  
Business Insights, Jan 2010, Pages: 158
to R&D outsourcing strategy, supplier evaluation & selection, contracting, project organization and expectations, supplier management, culture, staff turnover and intellectual property. Key features


Emerging Clinical Trial Locations –Latin America: Market Dynamics and the Changing Healthcare and Regulatory Environment  
Business Insights, June 2009, Pages: 144
Introduction Conducting clinical trials in emerging markets Latin America Chapter 1 Introduction Summary Introduction Generic competition Intellectual property protection Managing regulatory compliance


Emerging Clinical Trial Locations – China: Market Dynamics and the Changing Healthcare and Regulatory Environment  
Business Insights, June 2009, Pages: 143
of review by institutional review board (IRB) Absence of informed consent Scientific validity Inadequate protection of intellectual property Clinical trial logistics Import licenses and applications


Organic Electronics - Global Strategic Business Report  
Global Industry Analysts, Inc., Oct 2011, Pages: 584
Takes Over Gracel Display 43 Dupont to Enter into an Alliance with Dainippon Screen 44 Merck Enters into Partnership with DELO 44 Merck to Acquire the Intellectual Property Portfolio of OLED-T 44 CDT


Early Stage and Discovery Deals: Strategy, Structure and Payment Terms, 2nd Edition  
Pharmalicensing Ltd., Dec 2006, Pages: 144
to the deal valuation 6.4.1.1. Intellectual property 6.4.1.2. Development phase 6.4.1.3. Cost of clinical trials 6.4.1.4. Risks associated with commercializing too late 6.4.1.5. Benchmark values 6.4.1.6.


Almirall, S.A. - Product Pipeline Review - H2 2011  
Global Markets Direct, Oct 2011, Pages: 101
with Almirall, S.A.. - Avoid Intellectual Property Rights related issues. - Explore the dormant and discontinued projects of Almirall, S.A. and identify potential opportunities in those areas. List


Genetic Testing - Global Strategic Business Report  
Global Industry Analysts, Inc., Jan 2011, Pages: 354
Kits 6. RECENT INDUSTRY ACTIVITY Transgenomic Licenses Intellectual Property from Integragen Signal Genetics Collaborates with Array BioPharma Genzyme Divests Genetic Testing Business


Carbon Nanotubes - Global Strategic Business Report  
Global Industry Analysts, Inc., Sep 2010, Pages: 343
21 Other Applications 22 Acquisition of Intellectual Property Rights 22 Patents Offer Multiple


ProStrakan Group plc - Product Pipeline Review - Q4 2010  
Global Markets Direct, Dec 2010, Pages: 67
. - Exploit collaboration and partnership opportunities with ProStrakan Group plc. - Avoid Intellectual Property Rights related issues. - Explore the dormant and discontinued projects of ProStrakan Group plc


From Innovation to Cash Flows: Value Creation by Structuring High Technology Alliances  
John Wiley and Sons Ltd, Aug 2009, Pages: 618
of Inventor, Innovator, and Entrepreneur. - Closing Thoughts. CHAPTER 2. PROTECTING YOUR INVENTION. - What Is Intellectual Property? - How Intellectual Property Law Works. - Basic Forms of Intellectual


The Outlook for Pharmaceuticals in Central Asia  
Espicom Business Intelligence Ltd, Nov 2011
QUARTERLY MARKET OUTLOOK Current market size Unique 5-Year market projections to 2012 Market outlook Comment & rating, covering 8 key areas such as use of generic drugs, intellectual property, pricing


Results:  First -   Prev -   1 -   2 -   3 -   4 -   5 -   6 -   Next -   Last


For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds